Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VH032-PEG5-C6-Cl (HaloPROTAC 2) is a small molecule HaloPROTAC that incorporates the VH032 based VHL ligand and 5-unit PEG linker. VH032-PEG5-C6-Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | VH032-PEG5-C6-Cl (HaloPROTAC 2) is a small molecule HaloPROTAC that incorporates the VH032 based VHL ligand and 5-unit PEG linker. VH032-PEG5-C6-Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays[1]. |
In vitro | Treatment with VH032-PEG5-C6-Cl for 24 hours results in approximately 70% degradation of GFP-Halotag7 at a concentration of 2.5 μM[1]. |
Synonyms | HaloPROTAC 2 |
Molecular Weight | 783.41 |
Formula | C38H59ClN4O9S |
CAS No. | 1799506-06-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (63.82 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VH032-PEG5-C6-Cl 1799506-06-1 Others VH032PEG5C6Cl HaloPROTAC 2 VH-032-PEG5-C6-Cl VH032 PEG5 C6 Cl inhibitor inhibit